p53 polymorphisms: cancer implications

Area of Science:

• Genetics
• Cancer Biology
• Molecular Oncology

Background:

• The p53 protein is a critical tumor suppressor, and its normal function is essential for preventing cancer development.
• Mutations in the TP53 gene are frequently observed in human tumors, leading to significant loss of p53 function.
• In contrast to cancer-causing mutations, naturally occurring TP53 single nucleotide polymorphisms (SNPs) are generally thought to have minimal impact on p53 function.

Purpose of the Study:

• To review the TP53 gene locus polymorphisms and their potential to influence cancer-related phenotypes.
• To discuss polymorphic variants in the p53 pathway, such as MDM2, and their potential biological consequences, individually or in combination with TP53 variants.

Main Methods:

• Literature review of TP53 gene variations and their functional consequences.
• Analysis of existing data on single nucleotide polymorphisms (SNPs) within the TP53 gene.
• Examination of studies investigating the role of MDM2 polymorphisms in cancer.

Main Results:

• While TP53 mutations are hallmarks of cancer, most TP53 SNPs are unlikely to cause significant functional defects in p53.
• Certain TP53 polymorphisms may have subtle effects on p53 function, potentially influencing cancer risk or phenotype.
• Polymorphisms in interacting genes, like MDM2, can modify the biological impact of TP53 variants.

Conclusions:

• The functional impact of TP53 polymorphisms on cancer is an area requiring further investigation.
• Understanding the interplay between TP53 variants, SNPs, and other pathway components like MDM2 is crucial for a comprehensive view of cancer biology.
• This review highlights the importance of considering genetic variations beyond canonical mutations in the context of cancer etiology and progression.